Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.12% | 283.74 | 1.5% | $847.25m | |
| GILD | Gilead Sciences, Inc. | 0.98% | 86.26 | 1.0% | $795.01m | |
| MRNA | Moderna, Inc. | -0.23% | 176.40 | 0.0% | $769.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.01% | 312.98 | 1.9% | $482.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 736.23 | 2.6% | $473.28m | |
| BIIB | Biogen, Inc. | 0.56% | 305.15 | 1.8% | $355.07m | |
| ILMN | Illumina, Inc. | -1.39% | 218.99 | 3.2% | $270.73m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.70% | 2.78 | 0.7% | $194.33m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.89% | 96.92 | 4.2% | $161.47m | |
| BNTX | BioNTech SE | -0.88% | 154.85 | 0.0% | $152.12m | |
| MRTX | Mirati Therapeutics, Inc. | 2.89% | 98.62 | 1.6% | $132.21m | |
| TECH | Bio-Techne Corp. | 0.79% | 338.97 | 4.5% | $123.89m | |
| AXSM | Axsome Therapeutics, Inc. | 1.07% | 56.82 | 1.6% | $80.71m | |
| NVAX | Novavax, Inc. | -2.88% | 16.54 | 75.3% | $70.44m | |
| HALO | Halozyme Therapeutics, Inc. | 0.59% | 54.67 | 18.4% | $64.50m |
Company Profile
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.